November 23, 2016
Eli Lilly announces negative results from Phase III study of solanezumab
Eli Lilly announced that a Phase III study (EXPEDITION3 trial) of the anti-amyloid drug solanezumab in people with mild Alzheimer’s did not find a statistically significant slowing of cognitive decline in treated patients versus those who received placebo. The Alzheimer’s Association is disappointed with the negative results of this clinical trial and hopes that ongoing Alzheimer's prevention trials testing the drug will continue.
November 22, 2016
JAMA Internal Medicine article reports reduction in U.S. dementia prevalence rate
A new JAMA Internal Medicine article reports a reduction in the percentage of older people with dementia between 2000 and 2012. These findings, in addition to other similar studies and data published in the Alzheimer's Association Alzheimer's Disease Facts and Figures report, strongly suggest that risk for dementia can be reduced. However, there is an important difference between prevalence rate and prevalence number, which the Alzheimer's Association believes is still increasing.
November 14, 2016
Alzheimer's Association ready to work with new administration and new Congress
The Alzheimer’s Association is ready for the next stage of advancing public policy to improve the lives of the more than 5 million Americans living with Alzheimer’s disease and their 15 million caregivers, working collaboratively with the Trump administration and the 115th Congress.
November 3, 2016
Medicare to provide coverage for critical care and support services for individuals living with Alzheimer's disease
The Centers for Medicare & Medicaid Services (CMS) has finalized its decision to pay for cognitive and functional assessments and care planning for people living with Alzheimer's disease and other cognitive impairments. For the first time, people living with Alzheimer's will have access to care planning with a medical professional.
October 3, 2016
Alzheimer's Association mourns the death of researcher Allen Roses, M.D.
The Alzheimer's Association is saddened to learn of the death of pioneering researcher Allen Roses, M.D. Roses was a visionary and innovator in the fields of neurology, genetics and drug development.
Alzheimer's Association mourns the death of researcher Dale Schenk, Ph.D.
The Alzheimer's Association is saddened to learn of the death of scientist Dale Schenk, Ph.D., who devoted his career to researching brain diseases such as Alzheimer's and Parkinson's.
August 30, 2016
Alzheimer's Association accelerates research on potential sex differences in Alzheimer's
The first-ever Alzheimer's Association Sex and Gender in Alzheimer's (SAGA) research grant awards will provide $2.2 million to nine projects to advance understanding of the disproportionate effect of Alzheimer's disease on women.
August 29, 2016
Study examines relationship between PTSD and cognitive impairment in World Trade Center responders
New research published by the journal Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring confirms the connection between posttraumatic stress disorder (PTSD) and cognitive impairment — in this case, among those who helped with search, rescue and cleanup efforts following the 2001 World Trade Center attacks.
August 9, 2016
Second Alzheimer's professional judgment budget reflects urgent need to find a cure or treatment
The National Institutes of Health (NIH) recommended in its second-ever professional judgment budget for Alzheimer’s research a $414 million increase for FY2018 annual spending “to meet one of the greatest challenges of our time ― the development of effective treatments for and prevention of Alzheimer’s and related dementias by 2025.”
August 2, 2016
Alzheimer's Association issues $7 million challenge to scientists to speed drug discovery
The Alzheimer’s Association, in partnership with a fundraising initiative led by philanthropist Michaela “Mikey” Hoag, announced a new $7 million investment in clinical trials that target brain inflammation as an innovative avenue for Alzheimer’s disease therapy.
July 20, 2016
Sigma Kappa supports Alzheimer's Association with $1 million gift
Sigma Kappa Foundation presented the Alzheimer's Association with the $1 million lead gift for the Women's Alzheimer's Research Initiative at Sigma Kappa's 87th National Convention held in Chicago. The gift will fund innovative research focused on women including studies to understand why more women are living with this disease and studies led by female researchers working to advance Alzheimer's and dementia science.
July 14, 2016
Alzheimer’s research funding receives bipartisan support in House
Today, the House Appropriations Committee approved an additional $350 million for Alzheimer’s disease research. The Alzheimer’s Association, the leading advocate for federal Alzheimer’s disease research funding and caregiver support, and its advocates applaud the bipartisan action of the House Appropriations Committee to approve a significant increase for Alzheimer’s disease research funding at the NIH.
July 13, 2016
Alzheimer’s Association advocate shares personal experience and urges Congress to increase support for caregivers
Speaking on behalf of the more than 15 million Americans providing care to the more than 5 million Americans living with Alzheimer’s, Alzheimer’s Association advocate Connie Bastek-Karasow urged Congress to work to improve the Medicare system to provide better care for American families facing this diagnosis until a scientific breakthrough leads to an effective treatment or cure for the disease.
July 12, 2016
Alzheimer’s Association celebrates milestone for care and support services announced by CMS
Following rapidly growing bipartisan support in Congress for the Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act, the Centers for Medicare & Medicaid Services (CMS) has proposed to begin paying for cognitive and functional assessment and care planning for people with Alzheimer’s disease and other cognitive impairments.
July 6, 2016
House hears the call of Alzheimer’s Association advocates, proposes critical research funding increase
Today, the House Labor-HHS Appropriations Subcommittee proposed a $350 million increase for Alzheimer’s research at the NIH. This bipartisan effort was led by Alzheimer’s champion Chairman Tom Cole (R-Okla.) and comes just weeks after the Senate Appropriations Committee proposed a historic $400 million increase.
June 26, 2016
Alzheimer's Association mourns death of legendary basketball coach Pat Summitt
The Alzheimer's Association was saddened to learn about the death of legendary basketball coach Pat Summitt. Already a trailblazer, becoming the winningest Division 1 coach in NCAA history, Coach Summitt led the way by bravely disclosing her younger-onset Alzheimer's diagnosis in May 2011.
June 9, 2016
Alzheimer's Association celebrates extraordinary week
Today, the Senate Appropriations Committee approved a $400 million increase in Alzheimer's disease research funding at the NIH and included the Health Outcomes, Planning, and Education (HOPE) for Alzheimer's Act in its funding bill. The Alzheimer's Association applauds the committee for this momentous action in the journey to end the Alzheimer's epidemic — and in improving support for those who face the disease today.
June 7, 2016
Senate makes monumental commitment to care and support
Today, the Alzheimer’s Association and its relentless advocates, applaud the Senate Labor-HHS Appropriations Subcommittee for its commitment to the more than 5 million Americans living with Alzheimer’s disease and their more than 15 million caregivers. In a bipartisan effort, the committee included the Health Outcomes, Planning, and Education (HOPE) for Alzheimer’s Act (S. 857) in its funding bill. Since its inception, the Alzheimer’s Association has been intricately involved with its creation and strongly endorsed the HOPE for Alzheimer’s Act upon introduction by Senator Debbie Stabenow (D-MI).
June 6, 2016
Alzheimer's research funding on path for additional $400 million increase
Today, the call for increased Alzheimer's research funding from Alzheimer's Association advocates reached a critical milestone, as the Senate Labor-HHS Appropriations Subcommittee announced a proposed $400 million increase for Alzheimer's research at the NIH. This bipartisan effort was led by Alzheimer's champions Chairman Roy Blunt (R-Mo.) and Ranking Member Patty Murray (D-Wash.), who also oversaw last year's historic funding increase.
June 1, 2016
"Uncovering the truth about Alzheimer's" confronts damaging myths about the disease
To improve the public’s understanding of Alzheimer's and to underscore the need for swift action, the Alzheimer’s Association is highlighting essential truths aimed at curbing common misconceptions about the disease during Alzheimer's & Brain Awareness Month in June.
April 29, 2016
The Alzheimer’s Association responds to news that film under development would depict President Ronald Reagan's dementia as a comedic device
The Alzheimer’s Association is appalled that anyone would plan to develop a film that satirizes an individual living with Alzheimer's or another dementia.
April 23, 2016
Alzheimer's Association awards $4.3 million to accelerate the launch of new drug treatment arms in landmark prevention trial
The Alzheimer's Association announces a new $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer's Network Trials Unit (DIAN-TU) known as DIAN-TU Next Generation (NexGen). This award will accelerate the testing of new potential Alzheimer's therapies and a new diagnostic approach in people with genetically based, younger-onset Alzheimer's disease using an innovative trial design that is being applied to Alzheimer's for the first time.
April 13, 2016
Bipartisan Legislation Offering Critical Support for Older Americans Passes in Senate, House
The Alzheimer’s Association and its nationwide network of advocates celebrate the passage of the Older Americans Act (OAA) Reauthorization Act of 2016.
April 6, 2016
David Hyde Pierce Shares Personal Experience with Alzheimer's, Urges Congress to Increase Support for Caregivers
Emmy Award-winning actor David Hyde Pierce today praised Congress for its continued commitment to increasing research funding for Alzheimer's and called for additional funding for research and similar progress supporting people with Alzheimer's disease and their families.
April 6, 2016
Alzheimer's Association Applauds Introduction of Palliative Care and Hospice Education and Training Act
The Alzheimer's Association and its nationwide network of advocates strongly supports the Palliative Care and Hospice Education and Training Act (PCHETA) (S.2748), introduced in the Senate by Senator Tammy Baldwin (D-WI).
March 30, 2016
Alzheimer's Association report shows care contributors sacrifice own food and medical care to support person with Alzheimer's disease
The personal financial support required by a person with Alzheimer's disease may ultimately deprive care contributors of basic necessities, such as food, transportation and medical care, according to the 2016 Alzheimer's Disease Facts and Figures report released today.
March 6, 2016
Alzheimer's Association mourns death of former first lady and Alzheimer's disease champion
The Alzheimer's Association was saddened to learn of the passing of former first lady and Alzheimer's advocate, Nancy Reagan. Mrs. Reagan was a long-standing honorary member of the Alzheimer's Association National Board of Directors and her involvement in the cause inspired the Alzheimer's community of families, caregivers and researchers.
March 2, 2016
Patient enrollment opens for largest brain amyloid scanning research study
Participating dementia specialists may now enroll patients to participate in the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study at IDEAS-Study.org. Primary care and other doctors not taking part in the IDEAS Study are encouraged to refer eligible patients to participating physicians.
February 25, 2016
Alzheimer's Association participates in global leadership of the World Dementia Council
While the Alzheimer's Association and its counterparts in other nations are on the front lines of this epidemic, we cannot do it alone. Governments and industry must be actively engaged and all those affected must raise their voices, illustrating the importance of the World Dementia Council (WDC).
February 16, 2016
Alzheimer's Association and Edward Jones partner to change the course of Alzheimer's for millions
The Alzheimer's Association today announced a historic partnership with St. Louis-based financial services firm Edward Jones. which has committed $4.7 million over two years to support the Association's mission.
February 10, 2016
Landmark study finds U.S. dementia incidence highest in African-Americans and American Indians
The first study to look at dementia risk in a population representing the diversity of the United States finds dementia incidence to be highest in African-Americans and lowest in Asian-Americans.